¼¼°èÀÇ µðÁöÅÐ ¾à±¹ ½ÃÀå
Digital Pharmacy
»óǰÄÚµå : 1758171
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 279 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,198,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,594,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ µðÁöÅÐ ¾à±¹ ½ÃÀå, 2030³â±îÁö 3,204¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 1,313¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ µðÁöÅÐ ¾à±¹ ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â¿¡ CAGR 16.0%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 3,204¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀΠ󹿾à ÀǾàǰÀº CAGR 14.3%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 1,912¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. OTC(Over-the-Counter) ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 18.9%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 358¾ï ´Þ·¯, Áß±¹Àº CAGR 21.0%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹Ãø

¹Ì±¹ÀÇ µðÁöÅÐ ¾à±¹ ½ÃÀåÀº 2024³â¿¡ 358¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 691¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 21.0%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 12.0%¿Í 14.3%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 12.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ µðÁöÅÐ ¾à±¹ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

µðÁöÅÐ ¾à±¹ ¸ðµ¨Àº ÀüÅëÀûÀÎ ÀÇ·á À¯ÅëÀ» ¾î¶»°Ô ÆÄ±«Çϰí Àִ°¡?

µðÁöÅÐ ¾à±¹ Ç÷§ÆûÀº ¿£µåÅõ¿£µå ÀǾàǰ °ü¸®¸¦ Á¦°øÇÏ´Â ¾Û°ú À¥ ±â¹Ý ¼­ºñ½º¸¦ ÅëÇØ ¿ÀÇÁ¶óÀÎ ¾à±¹À» ´ëüÇÔÀ¸·Î½á ÀǾàǰ ó¹æ, Á¶Á¦ ¹× ¹è¼Û ¹æ½Ä¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ç÷§ÆûÀ» ÅëÇØ ȯÀڴ ó¹æÀüÀ» ¾÷·ÎµåÇϰí, ¸éÇ㸦 °¡Áø ¾à»ç¿Í ¿Â¶óÀÎÀ¸·Î »ó´ãÇϰí, ¹®¾Õ¿¡¼­ Á÷Á¢ ¾àÀ» ¼ö·ÉÇÒ ¼ö ÀÖ½À´Ï´Ù. µðÁöÅÐ ¾à±¹Àº ó¹æÀü °ü¸®ºÎÅÍ ¸®ÇÊ ¸®¸¶Àδõ±îÁö ¿öÅ©Ç÷ο츦 µðÁöÅÐÈ­ÇÔÀ¸·Î½á ÆíÀǼº, ÇÁ¶óÀ̹ö½Ã, È¿À²¼ºÀ» Á¦°øÇÕ´Ï´Ù.

ÀÌ·¯ÇÑ º¯È­´Â µðÁöÅÐ ÇコÄÉ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼­, ƯÈ÷ Àü ¼¼°è °Ç°­ ÆÄ±«·Î ÀÎÇØ ÀüÅëÀûÀÎ ¾à±¹ Á¢±Ù¼º¿¡ ´ëÇÑ °ÝÂ÷°¡ µå·¯³­ ÀÌÈÄ ´õ¿í °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. µðÁöÅÐ ¾à±¹Àº ó¹æÀü ÀÀ´ë»Ó¸¸ ¾Æ´Ï¶ó ¿ø°Ý »ó´ã, À£ºù Á¦Ç°, ¸¸¼ºÁúȯ °ü¸® Áö¿ø µîÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ±¤¹üÀ§ÇÑ »ýŰè´Â ½Ã°£¿¡ Âѱâ´Â ¼ÒºñÀÚ, ÀçÅà ȯÀÚ, Àå±â Ä¡·á °ü¸®ÀÚ¿¡°Ô ¾îÇÊÇϸç ÀǾàǰ Á¦°øÀ» º¸´Ù ȯÀÚ Áß½ÉÀûÀÎ ¼­ºñ½º ¸ðµ¨·Î ÀçÆíÇϰí ÀÖ½À´Ï´Ù.

µðÁöÅÐ ¾à±¹ ¼­ºñ½º È®ÀåÀ» Áö¿øÇÏ´Â ±â¼úÀº ¹«¾ùÀΰ¡?

µðÁöÅÐ ¾à±¹ ¿î¿µÀº Çコ Å×Å© Åø, ¹°·ù ½Ã½ºÅÛ, µ¥ÀÌÅÍ ºÐ¼®ÀÇ °ß°íÇÑ À¶ÇÕÀ¸·Î Áö¿øµÇ¸ç, AI ±â¹Ý Ç÷§ÆûÀº ó¹æÀü È®ÀÎ, º¹¾à ¼øÀÀµµ ¸ð´ÏÅ͸µ, ¾à¹° »óÈ£ ÀÛ¿ë °æ°í¸¦ µ½½À´Ï´Ù. ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀº Àç°í °ü¸®¸¦ ÃÖÀûÈ­Çϰí, º¸Ãæ ¼ö¿ä¸¦ ¿¹ÃøÇϸç, ȯÀÚ¿ÍÀÇ Ä¿¹Â´ÏÄÉÀ̼ÇÀ» °³ÀÎÈ­ÇÕ´Ï´Ù. ÀüÀڰǰ­±â·Ï(EHR)°úÀÇ ÅëÇÕÀ» ÅëÇØ ÀÇ»ç¿Í ¾à±¹ °£ÀÇ Ã³¹æÀü ¾÷µ¥ÀÌÆ®¸¦ µ¿±âÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù.

÷´Ü ¹°·ù ¼ÒÇÁÆ®¿þ¾î´Â È¿À²ÀûÀÎ ¶ó½ºÆ® ¸¶ÀÏ ¹è¼ÛÀ» º¸ÀåÇϰí, ÀÚµ¿ Á¶Á¦ Àåºñ´Â ÀÎÀû ¿À·ùÀÇ À§ÇèÀ» ÁÙÀÔ´Ï´Ù. ºí·ÏüÀÎ ±â¼úÀº ó¹æÀüÀÇ ½Å·Ú¼º°ú Àüü °ø±Þ¸ÁÀÇ ÃßÀû¼ºÀ» º¸ÀåÇϱâ À§ÇØ ¿¬±¸µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¸ð¹ÙÀÏ ¾ÛÀº ÁÖ¹® °ü¸®, ½Ç½Ã°£ ¾÷µ¥ÀÌÆ® ¼ö½Å, °¡»ó ¾à»ç¿ÍÀÇ ´ëÈ­ ¿¹¾à, °Ç°­ Á¤º¸ ¾×¼¼½º µîÀ» À§ÇÑ »ç¿ëÀÚ ´ë½Ãº¸µå¸¦ Á¦°øÇÏ¿© ¿øÈ°ÇÑ µðÁöÅÐ °Ç°­ ¿©Á¤¿¡ ±â¿©ÇÕ´Ï´Ù.

¾î¶² ¼ÒºñÀÚ ºÎ¹®°ú ¼­ºñ½º ¸ðµ¨ÀÌ º¸±ÞÀ» ÃËÁøÇϰí Àִ°¡?

µðÁöÅÐ ¾à±¹Àº ƯÈ÷ ¸¸¼ºÁúȯÀ» °ü¸®ÇÏ´Â ±â¼ú¿¡ Á¤ÅëÇÑ ¼ÒºñÀÚ, Á¤±âÀûÀÎ ¾àǰ ¹è¼ÛÀ» ÇÊ¿ä·Î ÇÏ´Â ³ëÀÎ, ½Ã°£ Àý¾àÀ» ¿øÇÏ´Â ¹Ù»Û Àü¹®°¡, µµ½Ã °ÅÁÖÀÚµé »çÀÌ¿¡¼­ °­·ÂÇÑ ÁöÁö¸¦ ¹Þ°í ÀÖ½À´Ï´Ù. Á¤±âÀûÀÎ Åõ¾à ¼­ºñ½º³ª ´çÀÏ ¹è¼Û ¿É¼ÇÀº Áö¼ÓÀûÀÎ Ä¡·á°¡ ÇÊ¿äÇÑ È¯ÀÚµéÀÇ ÁöÁö¸¦ ¹Þ°í ÀÖ½À´Ï´Ù. µðÁöÅÐ ¿ì¼±ÀÇ ½ºÅ¸Æ®¾÷°ú ±âÁ¸ ¾à±¹ üÀÎ ¸ðµÎ µðÁöÅп¡ Àû±ØÀûÀÎ ¼ÒºñÀÚ¿¡ ´ëÀÀÇϱâ À§ÇØ ÀÌ ºÐ¾ß¿¡ ÁøÃâÇϰí ÀÖ½À´Ï´Ù.

º¸Çè»ç ¹× °í¿ëÁֵ鵵 ÀÇ·á ÇýÅÃÀÇ ÀÏȯÀ¸·Î ÅëÇÕ ¾à¹°Àü´ÞÀ» Á¦°øÇϱâ À§ÇØ µðÁöÅÐ ¾à±¹ ÇÁ·Î¹ÙÀÌ´õ¿Í Çù·ÂÇϱ⠽ÃÀÛÇß½À´Ï´Ù. ÇÑÆí, Áö¹æÀ̳ª ¼Ò¿ÜµÈ Áö¿ª ÁֹεéÀº ¿Â¶óÀÎ ÁÖ¹®°ú ¹°¸®Àû ¹è¼Û °ÅÁ¡À̳ª Ű¿À½ºÅ©¸¦ °áÇÕÇÑ ÇÏÀ̺긮µå ¸ðµ¨À» ÅëÇØ Ÿ°ÙÆÃµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ºÒÀÓ, Á¾¾çÇÐ, ÇǺΰú, Á¤½Å°Ç°­ µî Æ´»õ Ä¡·á ºÐ¾ß¿¡ ƯȭµÈ Àü¹® µðÁöÅÐ ¾à±¹µµ µîÀåÇÏ¿© ¸ÂÃãÇü ÀǾàǰ »ó´ã ¹× º¹¾à °ü¸® Áö¿øÀ» Á¦°øÇÕ´Ï´Ù.

µðÁöÅÐ ¾à±¹ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÈ­ÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

µðÁöÅÐ ¾à±¹ ½ÃÀåÀÇ ¼ºÀåÀº ¿ø°ÝÀÇ·á µµÀÔ Áõ°¡, ºñÁ¢ÃË½Ä ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ÀÏ»óÀûÀÎ À£´Ï½º ¿ä±¸¿¡ ´ëÇÑ ¸ð¹ÙÀÏ ¹× µðÁöÅÐ Ç÷§ÆûÀÇ »ç¿ë È®´ë µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°øÀÇ ÆíÀǼº°ú Åõ¸í¼º¿¡ ´ëÇÑ ¼ÒºñÀÚ ÇൿÀÇ º¯È­´Â ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ µðÁöÅÐ ¾à±¹ ±â´É¿¡ ÅõÀÚÇϵµ·Ï À¯µµÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀüÀÚó¹æÀü ¹× ÀÇ·á IT ÀÎÇÁ¶óÀÇ ºÎ»óÀ¸·Î µðÁöÅÐ ¾à±¹À» º¸´Ù ±¤¹üÀ§ÇÑ ÀÇ·á ¼­ºñ½º ³×Æ®¿öÅ©¿¡ ÅëÇÕÇÏ´Â °ÍÀÌ ´õ ½¬¿öÁö°í ÀÖ½À´Ï´Ù.

¸¸¼ºÁúȯ °ü¸® ÇÁ·Î±×·¥ÀÇ È®´ë, °í¿ëÁÖÀÇ µðÁöÅÐ °Ç°­ ±¸»ó Áõ°¡, ÇコÄÉ¾î ¼­ºñ½ºÀÇ ¼ÒºñÀÚÈ­ µî ÃÖÁ¾»ç¿ëÀÚ µ¿ÇâÀº µðÁöÅÐ ¾à±¹ Ç÷§Æû¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¼ö¿ä¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ÀüÀÚó¹æÀü, µ¥ÀÌÅÍ º¸È£, µðÁöÅÐ Çコ Çõ½Å¿¡ ´ëÇÑ ±ÔÁ¦ ´ç±¹ÀÇ Áö¿øÀº ÀÌ ºÐ¾ß¸¦ ´õ¿í °­È­½Ã۰í ÀÖ½À´Ï´Ù. ÀǾàǰ °ø±Þ¸ÁÀÌ °è¼Ó Çö´ëÈ­µÇ°í ȯÀÚµéÀÇ ±â´ë°¡ µðÁöÅÐ ÆíÀǼºÀ¸·Î À̵¿ÇÔ¿¡ µû¶ó µðÁöÅÐ ¾à±¹ ¸ðµ¨Àº ÀÇ·á Á¢±Ù¼º°ú º¹¾à ¼øÀÀµµÀÇ Áß½ÉÃàÀÌ µÉ Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù.

ºÎ¹®

ÀǾàǰ À¯Çü(󹿾à, OTC(Over-the-Counter) ÀǾàǰ); Ç÷§Æû(¾ÖÇø®ÄÉÀÌ¼Ç ±â¹Ý Ç÷§Æû, À¥ ±â¹Ý Ç÷§Æû)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÁÖ¸ñ 48»ç)

AI ÅëÇÕ

¿ì¸®´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå°ú °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM ¹× ¾÷°è °íÀ¯ SLMÀ» Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹üÀ» µû¸£´Â ´ë½Å¿¡ ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Digital Pharmacy Market to Reach US$320.4 Billion by 2030

The global market for Digital Pharmacy estimated at US$131.3 Billion in the year 2024, is expected to reach US$320.4 Billion by 2030, growing at a CAGR of 16.0% over the analysis period 2024-2030. Prescription Medicines Drugs, one of the segments analyzed in the report, is expected to record a 14.3% CAGR and reach US$191.2 Billion by the end of the analysis period. Growth in the Over-the-Counter Drugs segment is estimated at 18.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$35.8 Billion While China is Forecast to Grow at 21.0% CAGR

The Digital Pharmacy market in the U.S. is estimated at US$35.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$69.1 Billion by the year 2030 trailing a CAGR of 21.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.0% and 14.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.7% CAGR.

Global Digital Pharmacy Market - Key Trends & Drivers Summarized

How Is the Digital Pharmacy Model Disrupting Traditional Healthcare Distribution?

Digital pharmacy platforms are revolutionizing the way medications are prescribed, dispensed, and delivered by replacing physical storefronts with app- and web-based services that offer end-to-end pharmaceutical care. These platforms enable patients to upload prescriptions, consult with licensed pharmacists online, and receive medications directly at their doorstep. By digitizing workflows from prescription management to refill reminders, digital pharmacies offer convenience, privacy, and efficiency-especially in urban settings and during public health emergencies.

The shift is being driven by increasing consumer preference for digital healthcare solutions, particularly in the wake of global health disruptions that exposed gaps in traditional pharmacy access. Digital pharmacies not only fill prescriptions but also provide teleconsultations, wellness products, and chronic disease management support. This broader ecosystem appeals to time-pressed consumers, home-bound patients, and those managing long-term therapies-reshaping pharmaceutical delivery into a more patient-centric service model.

What Technologies Are Powering the Expansion of Digital Pharmacy Services?

Digital pharmacy operations are underpinned by a robust blend of healthtech tools, logistics systems, and data analytics. AI-powered platforms assist in prescription validation, dosage adherence monitoring, and drug interaction alerts. Machine learning algorithms optimize inventory management, predict refill needs, and personalize patient communication. Integration with electronic health records (EHRs) allows for synchronized prescription updates between physicians and pharmacies.

Advanced logistics software ensures efficient last-mile delivery, while automated dispensing units reduce the risk of human error. Blockchain technology is being explored to ensure prescription authenticity and traceability across the supply chain. Furthermore, mobile apps offer user dashboards for managing orders, receiving real-time updates, scheduling virtual pharmacist interactions, and accessing health information-all contributing to a seamless digital health journey.

Which Consumer Segments and Service Models Are Driving Adoption?

Digital pharmacies are gaining strong traction across urban populations, especially among tech-savvy consumers managing chronic diseases, the elderly requiring home delivery of recurring medications, and busy professionals seeking time-saving alternatives. Subscription-based medication services and same-day delivery options are drawing loyalty from patients with ongoing care needs. Digital-first startups and traditional pharmacy chains are both expanding into this space to serve digitally-engaged consumers.

Insurance companies and employers are also beginning to collaborate with digital pharmacy providers to offer integrated medication delivery as part of healthcare benefits. Meanwhile, rural and underserved populations are being targeted through hybrid models that combine online ordering with physical delivery hubs or kiosks. Specialized digital pharmacies are also emerging to cater to niche therapeutic areas such as fertility, oncology, dermatology, and mental health, offering targeted pharmaceutical counseling and medication management support.

What Factors Are Accelerating Growth in the Digital Pharmacy Market?

The growth in the digital pharmacy market is driven by several factors, including the rise in telehealth adoption, increasing demand for contactless healthcare services, and expanding use of mobile and digital platforms for everyday wellness needs. The shift in consumer behavior toward convenience and transparency in healthcare delivery is encouraging providers to invest in digital pharmacy capabilities. Additionally, the rise of e-prescriptions and health IT infrastructure is making it easier to integrate digital pharmacies into broader care delivery networks.

End-use trends such as the expansion of chronic disease management programs, increased employer-sponsored digital health initiatives, and the consumerization of healthcare services are creating sustained demand for digital pharmacy platforms. Regulatory support for e-prescribing, data protection, and digital health innovation is further bolstering the sector. As pharmaceutical supply chains continue to modernize and patient expectations shift toward digital convenience, digital pharmacy models are poised to become a central pillar of healthcare access and medication adherence.

SCOPE OF STUDY:

The report analyzes the Digital Pharmacy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Drug Type (Prescription Medicines Drugs, Over-the-Counter Drugs); Platform (Application-based Platform, Web-based Platform)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â